BA
The Boeing Company
BA has the edge over CRGO overall, supported by lower modeled downside and stronger fundamentals.
CRGO
Freightos Limited Ordinary shares
CRGO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CRGO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
CRGO's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
CRGO PE Valuation
CRGO has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CRGO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CRGO's losses to shrink, with revenue growing.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over CRGO on earnings quality, reporting a profit while its opponent remains loss making.
CRGO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.33 | +$0.10 |
| Q1 2026 | -$0.39 | +$0.07 |
| Q4 2025 | -$0.35 | +$0.11 |
| Q3 2025 | -$0.47 | -$0.14 |
| Q2 2025 | -$0.43 | $0.00 |
| Q1 2025 | -$0.46 | -$0.02 |
| Q4 2024 | -$0.46 | +$1.24 |
| Q3 2024 | -$0.33 | +$2.41 |
CRGO is still losing money, but far less than before: $0.33 per share over the past year, against $11.75 at its worst in late 2022.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over CRGO on profitability, with a higher operating margin.
CRGO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.7M | +3.4% |
| Q1 2026 | $7.2M | +3% |
| Q4 2025 | $7.4M | +12% |
| Q3 2025 | $7.7M | +24% |
| Q2 2025 | $7.4M | +31% |
| Q1 2025 | $6.9M | +30% |
| Q4 2024 | $6.6M | +25% |
| Q3 2024 | $6.2M | +21% |
CRGO has the edge over BA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -46% | +15 points |
| Q1 2026 | -66% | +1.2 points |
| Q4 2025 | -76% | +0.5 points |
| Q3 2025 | -57% | +22 points |
| Q2 2025 | -61% | +20 points |
| Q1 2025 | -67% | +35 points |
| Q4 2024 | -76% | +12 points |
| Q3 2024 | -79% | +103 points |
CRGO's operating margin was −46% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2021.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CRGO on cash generation, producing positive trailing cash flow while its opponent burns cash.
CRGO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.3M | +$1.5M |
| Q1 2026 | -$4.5M | -1735% |
| Q4 2025 | -$3M | +$1.6M |
| Q3 2025 | -$3.4M | -$347K |
| Q2 2025 | -$2.9M | -$107K |
| Q1 2025 | $274K | +$2M |
| Q4 2024 | -$4.5M | -$1.5M |
| Q3 2024 | -$3.1M | +$2.2M |
CRGO has burned cash in almost every quarter: −$12M over the past year, against −$10M the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CRGO Net Leverage
CRGO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CRGO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.1 | Neutral |
| Stochastic | 7.4 | Oversold |
CRGO's weekly RSI is 30 (neutral) and its Stochastic is 7 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CRGO PE vs Industrials Sector
| Metric | CRGO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CRGO has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CRGO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.81 | 6.2% below |
| 20 week MA | $1.08 | 30% below |
| 50 week MA | $1.63 | 53% below |
| 100 week MA | $2.28 | 67% below |
| 200 week MA | $2.53 | 70% below |
CRGO is in a downtrend: it's below all five of its weekly moving averages, and 70% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over CRGO on returns for 2026, with the stronger performance.
CRGO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.79 | $9.78 | -0.1% |
| 2022 | $9.78 | $10.2 | +3.8% |
| 2023 | $10.2 | $3.33 | -67% |
| 2024 | $3.33 | $2.85 | -14% |
| 2025 | $2.85 | $2.32 | -19% |
| 2026 YTD | $2.32 | $0.76 | -67% |
CRGO has finished three years in a row lower, and it's down 67% so far in 2026.